Frances T. Prado, FNP-C

Frances Prado practices at John Muir Medical Center - Walnut C - Imaging - HOPD in Walnut Creek, California.

Frances Prado's NPI, 1700120631, was assigned on November 15, 2012. Frances Prado holds California license 95001580.

Frances Prado's primary practice is John Muir Medical Center - Walnut C - Imaging - HOPD, at 1450 Treat Blvd, Walnut Creek, CA 94597.

Frances Prado's primary practice is John Muir Medical Center - Walnut C - Imaging - HOPD in Walnut Creek, California. Frances Prado is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is John Muir Medical Group. Dmand AI also links Frances Prado to 1 more hospital, 5 medical groups and 1 group practice or clinic, each named with a free account. Frances Prado's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Frances Prado practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Frances Prado's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Frances Prado is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, bursitis, chest wall injury, contact dermatitis, ear infection, eyelid inflammation and gastroenteritis among the conditions Frances Prado treats.

CMS data shows 203 Medicare services from Frances Prado across 5 procedure codes in 2024, for 159 Medicare patients. Medicare paid $11,819 for them. Every service was in an office.

CMS counts 159 Medicare patients who saw Frances Prado in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Frances Prado's median patient age at 40, with 62% women.

In 2024, Frances Prado wrote 224 Medicare Part D claims for 173 patients. 79% of them were for generic drugs. CMS names the drug for 106 of them, across 6 drugs with 11 or more claims each, at $789 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Frances Prado for performance year 2024, reported as part of a group. Frances Prado accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Frances Prado from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $124.